-+ 0.00%
-+ 0.00%
-+ 0.00%

Silexion Therapeutics extraordinary meeting again lacks quorum, proceeds under articles of association

PUBT·09/25/2026 20:06:20
Listen to the news
Silexion Therapeutics extraordinary meeting again lacks quorum, proceeds under articles of association
  • Silexion Therapeutics held an extraordinary general meeting on Sept. 23, 2026.
  • Shareholders rejected a plan to increase authorized share capital by 175,000,000 ordinary shares to 190,900,000 ordinary shares.
  • A 1-for-15 reverse share split authorization was also rejected, leaving the split unapproved and not implemented.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silexion Therapeutics Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004604), on September 25, 2026, and is solely responsible for the information contained therein.